2nd day Alinity I Analyzer maintenance service with required reagents

SOL #: 75D30126Q78791Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
Centers For Disease Control And Prevention
CDC OFFICE OF ACQUISITION SERVICES
ATLANTA, GA, 30333, United States

Place of Performance

Atlanta, GA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Jan 13, 2026
2
Last Updated
Jan 16, 2026
3
Submission Deadline
Jan 20, 2026, 5:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm-fixed-price purchase order to Abbott Laboratories for Alinity I Analyzer maintenance service and required reagents. This procurement is for urgent OEM support for the Division of Viral Hepatitis Laboratory Branch. Responses from interested parties are due by January 26, 2026.

Scope of Work

The requirement is for an "Alinity I Always on 2nd Day" service agreement for the Alinity I Analyzer instrument. This includes:

  • All repairs, replacements, and labor due to instrument failures.
  • Unlimited service visits (Monday-Friday, 8:00 a.m. to 5:00 p.m. local time, excluding holidays).
  • All repairs covering parts, labor, and travel.
  • Predictive maintenance (AlinIQ charge).
  • Emergency repair response within 24 hours (Monday-Friday local time).
  • Field application support.
  • Email and phone technical support during business hours (Monday-Friday).

The Alinity I Analyzer is critical for running FDA-cleared antigen and antibody assays for Hepatitis viruses, including Hepatitis C core antigen, and is a prototype instrument for FDA presubmission assays for Hepatitis D and E.

Contract & Timeline

  • Type: Sole Source, Firm-Fixed-Price Purchase Order (below SAT)
  • Authority: FAR 13.106-1(b)(1)(i) and 10 U.S.C. 2304(c)(1)
  • NAICS: 325413 (Pharmaceutical Preparation Manufacturing)
  • Set-Aside: None (Sole Source)
  • Response Due: January 26, 2026, 12:00 PM EST
  • Published: January 16, 2026
  • Solicitation Number: 75D30126Q78791

Additional Notes

The CDC intends to award to Abbott Laboratories as they are the original equipment manufacturer (OEM) and the only known source with access to proprietary reagents, diagnostics, and service infrastructure for the Alinity I Analyzer. This notice is not a request for competitive quotations; however, any quotations/responses received within fifteen (15) days of issuance will be considered to determine if a competitive procurement is feasible. Interested entities should email their capabilities to Gary Morgan at gmorgan1@cdc.gov.

People

Points of Contact

Gary MorganPRIMARY
Liubov KrielSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 2
Combined Synopsis/Solicitation
Posted: Jan 16, 2026
View
Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jan 13, 2026
2nd day Alinity I Analyzer maintenance service with required reagents | GovScope